- Dec 8, 2023
Study shows potential of new treatment strategies for most common childhood cancer
UBC Faculty of Medicine researchers at the BC Children’s Hospital Research Institute (BCCHR) have made a key discovery about how...
- Dec 5, 2023
Scientists discover new Achilles heel of leukemia cells
A team led by Jan-Henning Klusmann from the Department of Pediatrics and Dirk Heckl from the Institute for Experimental Pediatric...
- Nov 7, 2023
Childhood Leukemia Linked to Pesticides Used in Vineyards
A study published in Environmental Health Perspective finds the risk of acute childhood leukemia (AL), specifically acute lymphoblastic...
- Oct 10, 2023
FDA Approval of Bosulif Adds to Toolkit of Treatment Options for Children With CML
The Food and Drug Administration (FDA) has approved Bosulif (bosutinib) for the treatment of children as young as 1 year old with newly...
- Aug 23, 2023
Solving the Mystery of Long-Lasting Cancer Treatment – Scientists Reveal New Insights
Researchers from UCL, Great Ormond Street Hospital, and the Wellcome Sanger Institute have unveiled findings that shed light on why...
- Aug 11, 2023
Refined Stratification and Frontline Targeted Therapies Explored in Pediatric T-ALL
The treatment of pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) has benefited from numerous advancements in...
- Jul 17, 2023
Survival of children with acute lymphatic leukemia has increased to 94%, study finds
The five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is evident from a...
- Jul 7, 2023
BDR Pharma launches new drug for Philadelphia chromosome-positive leukemia
BDR Pharmaceuticals on Wednesday announced the launch of Nilotinib for a rare subtype of the most common childhood cancer, acute...